Furthermore, PHLPP levels may influence the initial response to TKIs, as low as PHLPP in pre-treatment specimens is strongly associated with reduced PFS for patients with EGFR-mutant lung adenocarcinomas treated with EGFR TKI. The gene discussed is EGFR; the disease is lung adenocarcinoma.